True empty follicle syndrome is a subtype of oocyte maturation abnormalities

Küçük Resim Yok

Tarih

2024

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Turkish Society of Obstetrics and Gynecology

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Objective: To review the outcomes of in vitro maturation (IVM) and in vitro fertilization (IVF) in women with empty follicle syndrome (EFS). The study evaluated the genetic underpinnings of EFS by analyzing mutations. Materials and Methods: This retrospective case series involving 17 women with EFS over at least 2 IVF cycles was conducted. The study also employed whole-exome sequencing to analyze the genetic mutations. The treatment approaches included letrozole-primed IVM, follicle-stimulating hormone (FSH)-human chorionic gonadotrophin (hCG)-primed IVM, and conventional IVF. Results: The average female age was 31.5±4.6 years, and the duration of infertility was 7.3±3.5 years. Four patients underwent IVF. IVM oocyte collections yielded oocytes in 12 of 13 subjects. Of these, 75% (9/12) yielded MII oocytes after 48 h of IVM media incubation. Six subjects had fertilized embryos, resulting in a 40.9% intracytoplasmic sperm injection (ICSI) fertilization rate (9 embryos/22 MII oocytes). Genetic analysis revealed mutations in seven patients. This study demonstrated the partial efficacy of letrozole-primed IVM plus growth hormone and FSH-hCG primed IVM protocols. No pregnancies or live births were recorded after IVM. One ongoing pregnancy post-IVF and one spontaneous live birth were observed. Conclusion: Inter-cycle variabilities were observed in women with oocyte maturation abnormalities (OMAs). Almost all patients with EFS had oocytes collected during IVM following IVF. These oocytes have limited potential for maturation, fertilization, and live birth, as demonstrated by the low rates observed after IVM culture and ICSI. These conditions are observed in OMAs due to defects in the oocyte machinery. The proposed flowchart provides a comprehensive classification approach for various forms of EFS. © 2024 Elsevier B.V., All rights reserved.

Açıklama

Anahtar Kelimeler

Empty Follicle Syndrome, In Vitro Maturation, Oocyte Maturation Abnormalities, Oocyte Maturation Arrest, Chorionic Gonadotropin, Estradiol Valerate, Follitropin, Growth Hormone, Human Growth Hormone, Letrozole, Progesterone, Testosterone, Thyrotropin, Kocak Farma, Qiacube Ht, Qiamp, Qiaseq Index I Set A Kit, Spss Statistics Version 21.0, Chorionic Gonadotropin, Estradiol Valerate, Follitropin, Growth Hormone, Human Growth Hormone, Kocak Farma, Letrozole, Progesterone, Testosterone, Thyrotropin, Adult, Article, Blastocyst, Clinical Article, Dna Extraction, Embryo Transfer, Empty Follicle Syndrome, Endometrial Thickness, Female, Female Infertility, Fertilization, Gene Mutation, Genetic Analysis, Gestational Age, Gestational Sac, Gynecologic Disease, Human, In Vitro Fertilization, In Vitro Oocyte Maturation, Intracytoplasmic Sperm Injection, Live Birth, Luteal Phase, Menstrual Cycle, Oocyte, Oocyte Maturation, Oocyte Retrieval, Oocyte Vitrification, Retrospective Study, Spontaneous Abortion, Transvaginal Echography, Whole Exome Sequencing, Young Adult

Kaynak

Turkish Journal of Obstetrics and Gynecology

WoS Q Değeri

Scopus Q Değeri

Q3

Cilt

21

Sayı

3

Künye